Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration
Clinical trial NCT05953012 · COMPLETED
Trial details
- NCT number
- NCT05953012
- Sponsor
- PharmAbcine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2025-08-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.